CCR8 and asthma: We have used two reagents, a highly selective monoclonal antibody to CCR8 developed by ICOS Corporation and fluorescently labelled CCL1 (Millennium Pharmaceuticals), to study the involvement of CCL1 and its receptor CCR8 in asthma.